TNF Pharmaceuticals, Inc. (LON:0A8D)
London
· Delayed Price · Currency is GBP · Price in USD 0.545
-0.022 (-3.84%)
At close: Feb 14, 2025
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of 1.04 million as of February 21, 2025. Its market cap has decreased by -81.48% in one year.
Market Cap
1.04M
Enterprise Value
-7.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since April 20, 2021, TNF Pharmaceuticals's market cap has decreased from 142.21M to 1.04M, a decrease of -99.27%. That is a compound annual growth rate of -72.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.04M | -58.75% |
| Dec 31, 2024 | 2.53M | -75.52% |
| Dec 29, 2023 | 10.34M | -72.56% |
| Dec 30, 2022 | 37.67M | -77.64% |
| Dec 31, 2021 | 168.49M | 18.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| Shell | 164.13B |
| HSBC Holdings | 156.44B |
| Unilever | 110.21B |
| Rio Tinto Group | 85.92B |
| RELX PLC | 73.75B |
| BP p.l.c. | 70.76B |
| British American Tobacco p.l.c. | 66.72B |